The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention

Scientific Reports
Jia-Ru WuJaw-Wen Chen

Abstract

There is limited information about the association between oat fiber intake and future cardiovascular events in CAD patients after coronary intervention for secondary prevention. This study enrolled 716 patients after coronary intervention in clinical stable status from the CAD cohort biosignature study. Patients were analyzed according to whether the presence of regular oat fiber intake during the follow-up period, and the association with endpoints including cardiovascular death, non-fatal myocardial infarction, non-fatal stroke and revascularization procedures were analyzed. The average follow-up period is 26.75 ± 8.11 months. Patients taking oat fiber were found to have lower serum levels of LDL, triglycerides, ratio of TC/HDL, as well as lower inflammatory markers values. After adjusting for confounders in the proportional hazard Cox model, oat fiber intake was associated with a lower risk of future revascularization (HR = 0.54, 95% CI 0.35-0.85; p = 0.007), and lower risk of major adverse cardiovascular events (HR = 0.62, 95% CI 0.43-0.88; p = 0.008), suggesting the association of oat fiber use and lower risk of future adverse event in CAD patients after coronary intervention.

References

Jan 30, 1999·The American Journal of Clinical Nutrition·L BrownF M Sacks
May 3, 2000·JAMA : the Journal of the American Medical Association·A K KantC Schairer
May 19, 2001·Critical Reviews in Oncogenesis·R P Pelley, F M Strickland
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Mar 17, 2004·The American Journal of Cardiology·Alain G BertoniDavid C Goff
Mar 10, 2005·The New England Journal of Medicine·John C LaRosaUNKNOWN Treating to New Targets (TNT) Investigators
Aug 2, 2005·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·N TapolaE Sarkkinen
Oct 8, 2008·Molecular Nutrition & Food Research·Julie-Anne NazareMartine Laville
Jun 18, 2010·Atherosclerosis·K E AnderssonP Hellstrand
Jun 12, 2013·Preventive Medicine·C Mary SchoolingHeidi E Jones
Nov 21, 2014·The American Journal of Clinical Nutrition·Anne WhiteheadThomas M S Wolever
Mar 3, 2015·The American Journal of Cardiology·Gang TangLiangyi Si
Jun 4, 2015·The New England Journal of Medicine·Christopher P CannonUNKNOWN IMPROVE-IT Investigators
Aug 28, 2016·European Heart Journal·Alberico L CatapanoUNKNOWN ESC Scientific Document Group
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators
Mar 30, 2017·Clinical Therapeutics·Stephanie R EarnshawJohn L Sievenpiper

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

© 2022 Meta ULC. All rights reserved